[Ip-health] Pharmaceutical global R&D was 7.9 percent of sales in 2010

Jamie Love james.love at keionline.org
Thu Jun 9 11:22:54 PDT 2011


Pharmaceutical global R&D was 7.9 percent of sales in 2010

Using industry assertions of R&D spending, pharmaceutical related R&D
spending by the private sector was less than 8 percent of global sales
in 2010.

[Graph: http://keionline.org/sites/default/files/u4/sales_rnd_2010.png]

These are the data:

2010 Global R&D by all private companies: - $67.4 billion
Source: Page 2 of the 2011 PhRMA industry profile

2010 Global sales - $856
Source: IMS Health Market Prognosis, March 2011

R&D / Sales = 0.078738318

How much of the 7.9 percent invested in R&D is invested in the
development of new products that are medically important? Given the
small number of FDA priority NCE approvals, that number is
significantly lower.

James Love.  Knowledge Ecology International
http://www.keionline.org, +1.202.332.2670, US Mobile: +1.202.361.3040,
Geneva Mobile: +41.76.413.6584, efax: +1.888.245.3140.

More information about the Ip-health mailing list